Related Experiment Video
Updated: May 27, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
Percutaneous coronary intervention versus coronary artery bypass graft in chronic kidney disease: Optimal treatment
Subrata Kar1, Walter Coats, Kul Aggarwal
1Division of Cardiovascular Medicine, University of Missouri Hospital and Clinics, Columbia, Missouri, USA.
Insights
For patients with chronic kidney disease (CKD), coronary artery bypass grafting is the optimal treatment for coronary artery disease (CAD). This approach reduces repeat procedures and improves long-term survival in CKD patients with CAD.
Area of Science:
- Nephrology
- Cardiology
- Cardiovascular Surgery
Background:
- Chronic kidney disease (CKD) is a global health issue, often progressing to end-stage renal disease.
- CKD significantly elevates the risk of coronary artery disease (CAD), a primary cause of mortality in affected individuals.
- Current invasive treatments for CAD include percutaneous coronary intervention and coronary artery bypass grafting.
Purpose of the Study:
- To determine the optimal treatment strategy for coronary artery disease (CAD) in patients with chronic kidney disease (CKD).
- To review current literature comparing invasive treatment options for CAD in the CKD population.
Main Methods:
- A comprehensive PubMed search was conducted.
- Literature review focused on identifying the best treatment for coronary artery disease in CKD patients.
Main Results:
- Coronary artery bypass grafting (CABG) demonstrated superiority over other invasive treatments.
- CABG was associated with reduced rates of repeat revascularization.
- Patients undergoing CABG experienced improved angina symptoms and increased long-term survival.
Conclusions:
- Coronary artery bypass grafting is the preferred treatment for coronary artery disease in patients with chronic kidney disease.
- CABG offers significant benefits including better symptom control, reduced need for repeat procedures, and enhanced long-term survival.
- This finding is crucial for managing cardiovascular health in the growing CKD population.
Abstract:
Chronic kidney disease (CKD) is ubiquitous in the world and may eventually progress to end-stage renal disease. CKD is associated with a greater risk of coronary artery disease (CAD) which is the leading cause of mortality in this population. Current invasive treatment options include percutaneous coronary intervention or coronary artery bypass graft. We performed a PubMed search to ascertain the optimal treatment for coronary artery disease in CKD. Our review of the current literature supports the superiority of coronary artery bypass grafting which reduces repeat revascularizations, improves angina symptoms, and increases long-term survival.
Related Concept Videos
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease I: Introduction
Kidney Transplant I: Introduction
Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Chronic Kidney Disease IV: Nursing Management